arrow
Back
M

Meg Jardine

University of Sydney

71H-index
410Paper Count
2.4WCitation Count
Published Papers 165
Publication Date
Epidemiology, mechanisms and clinical implications of heat-related kidney disease
err2026-09-16
err0
PREAI
errLucy McMullen; Alexandra Gallagher; Daniel Gagnon; Zachary J. Schlader; Zoltan H. Endre; Natasha M. Rogers; Timothy English; Shuchi Anand; Jason Glaser; Vivekanand Jha; Meg J. Jardine; Ollie Jay; Brendan Smyth
errShare
errSave
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: insights from the CREDENCE trial
err2026-09-04
err0
errOAAI
errEmily K Yeung; Amanda Siriwardana; Luke Buizen; Arthur H C Tang; Min Jun; Kevan R Polkinghorne; Sydney C W Tang; Sradha Kotwal; Clare Arnott; Adeera Levin; Meg Jardine; Soo Kun Lim; Vivekanand Jha; Kenneth W Mahaffey; Vlado Perkovic; Hiddo J L Heerspink; Brendon L Neuen
errShare
errSave
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality A Retrospective Observational Study Based on National General Practice Dataset
err2026-02-01
err0
PREAI
errSasaki, Takaya; Buizen, Luke; Harris, Katie; Badve, Sunil V.; Chalmers, John; Gallagher, Martin; Ha, Jeffrey T.; Jardine, Meg J.; Ketema, Daniel B.; Kotwal, Sradha S.; Neuen, Brendon L.; Ronksley, Paul E.; Wallace, Hannah; Yokoo, Takashi; Woodward, Mark; Jun, Min
errShare
errSave
A Phase 1B Trial of Cannabidiol for Symptom Management in Kidney Failure
err2025-11-19
err0
errOAAI
errBrendan Smyth; Taewon Yi; Kristy P. Robledo; Rebecca Gordon; Andrew J. McLachlan; Rachael L. Morton; Iain S. McGregor; Meg Jardine
errShare
errSave
Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset
err2025-10-01
err0
errOAAI
errLi, Angela Kathy; Kotwal, Sradha; Wallace, Hannah; Ketema, Daniel Bekele; Wick, James; Neuen, Brendon L.; Falster, Michael O.; Lin, Jialing; Pearson, Sallie-Anne; Peiris, David; Jardine, Meg J.; Woodward, Mark; Chalmers, John; Ronksley, Paul E.; Jun, Min
errShare
errSave
Changing paradigms of studies in kidney diseases
err2025-09-29
err0
errOAAI
errAdeera Levin; Allison Jaure; Dustin J. Little; Jane Schell; Jennifer S. Lees; Kai-Uwe Eckardt; Kevin Weinfurt; Matthias Rose; Meg J. Jardine; Morgan E. Grams; Patrick Schloemer; Rathika Krishnasamy; Smeeta Sinha; Fergus J. Caskey; Masaomi Nangaku; David C. Wheeler; Louise Oni; Jaquelyne T. Hughes; Bill Wang; Charles Cook; Duane Sunwold; Jocelyn Jones; Kate Chong; Thomas Ng; Jo-Ann Donner; Sandrine Damster; Charu Malik; Hiddo J.L. Heerspink
errShare
errSave
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset
err2025-07-16
err0
errOAAI
errHannah Wallace MBBS; James Wick MSc; Brendon L. Neuen PhD; Luke Buizen MStats; Sunil V. Badve PhD; John Chalmers PhD; Juliana de Oliveira Costa PhD; Michael O. Falster PhD; Jeffrey T. Ha PhD; Meg J. Jardine PhD; Daniel Bekele Ketema MPH; Jialing Lin PhD; Craig Nelson PhD; Sallie-Anne Pearson PhD; David Peiris PhD; Anthony Rodgers PhD; Takaya Sasaki PhD; Mark Woodward PhD; Martin Gallagher PhD; Sradha S. Kotwal PhD; Paul Ronksley PhD; Min Jun PhD
errShare
errSave
Patients’ Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study
err2025-06-17
err0
PREAI
errEdmund Y.M. Chung; Simon A. Carter; Allison Jaure; Martin Howell; Bhadran Bose; Meg Jardine; Lukas Kairaitis; Karen Keung; Hugh J. McCarthy; Nicole Scholes-Robertson; Amanda Sluiter; Germaine Wong; Stephen I. Alexander
errShare
errSave
errShare
errSave
The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials
err2025-03-01
err0
errOAAI
errNguyen, Tu N.; Yu, Jie; Perkovic, Vlado; Jardine, Meg; Mahaffey, Kenneth W.; Chow, Clara K.; Arnott, Clare; Lindley, Richard I.
errShare
errSave
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial
err2025-02-28
err0
PREAI
errBryony Beal; Luke Buizen; Emily K Yeung; Lauren Heath; Lauren Houston; David Z I Cherney; Meg Jardine; Carol Pollock; Clare Arnott; Sradha S Kotwal; Hiddo J L Heerspink; Vlado Perkovic; Brendon L Neuen
errShare
errSave
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
err2025-01-09
err0
PREAI
errSiriwardana, Amanda; Buizen, Luke; Jun, Min; Kotwal, Sradha; Arnott, Clare; Jardine, Meg J.; Levin, Adeera; Heerspink, Hiddo J. L.; Charytan, David M.; Pollock, Carol; Perkovic, Vlado; Neuen, Brendon L.
errShare
errSave
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: a participant level pooled analysis of CREDENCE and CANVAS
err2024-10-28
err0
PREAI
errChatur, S.; Neuen, B. L.; Fletcher, R. A.; Perkovic, V; Heerspink, H.; Arnott, C.; Pollock, C.; Mahaffey, K. W.; Neal, B.; Jardine, M.; Solomon, S. D.; Vaduganathan, M.
errShare
errSave
Bidirectional relationship between kidney disease progression and cardiovascular events in type 2 diabetes: new Insights from the CANVAS Program and CREDENCE trial
err2024-10-28
err0
PREAI
errNeuen, B. L.; Ostrominski, J. W.; Claggett, B. L.; Beldhuis, I; Chatur, S.; Arnott, C.; Heerspink, H. J. L.; Pollock, C.; Jardine, M.; Mahaffey, K. W.; Perkovic, V; Solomon, S. D.; Vaduganathan, M.
errShare
errSave
errShare
errSave
Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials
err2024-07-23
err1
PREAI
errNeuen, Brendon L.; Claggett, Brian L.; Perkovic, Vlado; Jardine, Meg; Heerspink, Hiddo J. L.; Mahaffey, Kenneth W.; McMurray, John J. V.; Solomon, Scott D.; Vaduganathan, Muthiah
errShare
errSave
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial (May, 10.1038/s41591-024-03043-1, 2024)
err2024-07-03
err0
errOAAI
errChertow, Glenn M.; Chang, Anna Marie; Felker, G. Michael; Heise, Mark; Velkoska, Elena; Fellstrom, Bengt; Charytan, David M.; Clementi, Regina; Gibson, C. Michael; Goodman, Shaun G.; Jardine, Meg; Levin, Adeera; Lokhnygina, Yuliya; Mears, Jenny; Mehran, Roxana; Stenvinkel, Peter; Wang, Angela Yee-Moon; Wheeler, David C.; Zoccali, Carmine; Ridker, Paul M.; Mahaffey, Kenneth W.; Tricoci, Pierluigi; Wolf, Myles
errShare
errSave
errShare
errSave
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial
err2024-06-26
err1
PREAI
errVaduganathan, Muthiah; Cannon, Christopher P.; Jardine, Meg J.; Heerspink, Hiddo J. L.; Arnott, Clare; Neuen, Brendon L.; Sarraju, Ashish; Gogate, Jagadish; Seufert, Jochen; Neal, Bruce; Perkovic, Vlado; Mahaffey, Kenneth W.; Kosiborod, Mikhail N.
errShare
errSave